查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球细胞分离市场：预测（2023-2028）
市场调查报告书
商品编码
1410101

全球细胞分离市场：预测（2023-2028）

Cell Separation Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2021年全球细胞分离市场规模达72.94亿美元。

预计细胞分离市场将在整个预测期内稳定成长。细胞分离是指从混合物或细胞群中分离特定类型细胞的过程。癌症等慢性病盛行率的增加和生物製药行业的扩张是细胞分离市场的主要成长动力。此外，对细胞分离市场的投资增加、意识的提高和干细胞研究计划正在进一步推动细胞分离市场的发展。

慢性疾病和感染疾病的负担增加

癌症、心臟病和自体免疫疾病等慢性疾病持续对全球健康产生严重影响。分离细胞的技术对于了解疾病原因、寻找疾病生物标记和製定专门的治疗方法至关重要。透过分离和分析循环性肿瘤细胞(CTC)，医生可以微创监测癌症患者对各种治疗的反应。因此，癌症等慢性疾病病例的增加预计将加强细胞分离市场。例如，根据世界卫生组织的数据，2020 年约有 1,000 万人（约六分之一的死亡人数）死于癌症，使其成为全球主要死亡原因。

不断发展的生物製药产业

随着新疗法和生技药品研发投资的增加，生物製药产业正在不断扩张。细胞分离技术对于单株抗体、重组蛋白和细胞疗法的生产至关重要。根据国家投资促进和便利化局的数据，生物製药产业是世界第三大产业。生物製药产业投资的增加直接推动了细胞分离市场的发展。例如，美国研究与製药工业协会 (PhRMA) 报告称，2019 年仅美国生物製药研究机构的研发支出就超过 1,000 亿美元。此外，Sun Pharma 董事总经理于 2022 年 2 月宣布投资 600-650 美元用于研究。

人们对干细胞研究的认识不断增强

干细胞研究在再生医学、疾病建模和药物开发方面具有巨大潜力。干细胞的分离和表征需要有效的细胞分离技术。人们对干细胞研究和各种调查的认识不断提高，正在推动细胞分离市场的发展。再生医学创新计划是根据2021年《21世纪治疗方法》设立的。该倡议由 NIH 和 FDA 采取，旨在加速干细胞领域的进展。此外，加州再生医学研究所将十月的第二个星期三庆祝为“干细胞意识日”，以共用有关干细胞和再生医学的想法、想法和进展。

加大投资力道和政府支持

参与细胞分离解决方案的公司获得的投资和资金的增加预计将在未来几年推动细胞分离市场的发展。例如，Nodexus Inc.筹集了 3000 万美元资金，以推进和扩大其 NX One 平台的商业化。 NX One 平台是世界上第一个用于从生物样本中分选和分离单细胞的自适应系统。此外，政府对推广细胞分离解决方案的支持和津贴进一步推动了细胞分离市场的发展。例如，Proteios Technology Inc. 于 2022 年 9 月获得 NIH 的 160 万美元津贴，用于将其多元细胞分离技术商业化。

市场抑制因素

儘管细胞分离市场正在经历成长和开拓，但一些抑制因素和挑战可能会影响其扩张。细胞分离的专一性可能受到所采用的分离方法的限制。例如，使用磁珠的分离技术可以因为特异性结合而共分离非目标细胞。一些细胞分离技术，例如萤光激活细胞分选 (FACS) 和微流体技术，需要专门的技术知识才能使用和理解结果。贫穷国家缺乏专家可能会阻碍细胞分离市场的扩张。一些细胞分离方法具有通量和可扩展性限制。当处理大量样品时，这可能是一个限制。

预计北美地区将出现显着成长

预计在预测期内，北美将占据细胞分离市场的主要份额。造成这一份额的因素包括成熟的製药和生物技术领域以及美国最尖端科技的广泛使用。例如，2022 年 9 月，美国总统推出了生物技术和生物製造倡议，以充分发挥生物技术的潜力。此外，该地区慢性病的高盛行率增加了对细胞分离产品的需求，从而推动了细胞分离市场的发展。例如，根据 CDC 的数据，癌症是美国第二大死因，2021 年约有 190 万例癌症。

主要市场参与者

Terumo Corporation 是一家日本跨国公司，致力于开发各种医疗设备，包括细胞分离相关产品。透过 Terumo BCT（血液成分技术）分店，我们提供各种细胞分离和处理技术。默克公司是一家总部位于德国的全球科技公司。我们提供与细胞分离及邻近产业相关的各种产品和服务。 Estapor (R) 顺磁性微球是可以使用简单的磁性方法分离目标细胞和微生物的试剂。 STEMCELL Technologies Inc.是一家加拿大生物技术公司，专注于干细胞研究、细胞治疗和再生医学领域的研究、开发、工具、试剂和服务。 Robosep(TM)-C 人类 T 细胞分离试剂盒、Robosep(TM)-C 管道套件是该公司作为细胞分离解决方案提供的部分产品。

新兴市场的主要发展

2023年5月，Akadeum推出了用于T细胞分离和扩增的GMP级产品线。本产品能够直接分离白斑人体免疫细胞，并透过微气泡活化T细胞来活化T细胞。 2022 年 2 月，GPB Scientific 宣布推出 Curate® Cell 平台，以简化细胞治疗和分离流程。 2020年6月，LevitasBio推出了其旗舰产品LeviCeIITM，作为细胞分离和分选的新方法。它提供了一种快速可靠的方法来分选完全存活的细胞群，同时提供无标定细胞分离。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 先决条件

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场抑制因素
  • 波特五力分析
  • 产业价值链分析

第五章细胞分离市场：副产品

  • 介绍
  • 消耗品
  • 装置

第六章细胞分离市场：依技术分类

  • 介绍
  • 离心
  • 表面标誌物
  • 滤

第七章细胞分离市场：依应用

  • 介绍
  • 生物分子分离
  • 癌症研究
  • 干细胞研究
  • 组织再生
  • 体外诊断
  • 治疗

第八章细胞分离市场：依最终用途

  • 介绍
  • 研究所/研究所
  • 医院/诊断实验室
  • 细胞库
  • 生物技术和生物製药公司

第九章细胞分离市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第十章竞争环境及分析

  • 主要企业及策略分析
  • 新兴企业和市场盈利
  • 合併、收购、协议和合作
  • 供应商竞争力矩阵

第十一章 公司简介

  • Thermo Fisher Scientific, Inc.
  • BD Biosciences
  • Danaher
  • Terumo Corp.
  • STEMCELL Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Corning Inc.
  • Akadeum Life Sciences
简介目录
Product Code: KSI061615766

The cell separation market was valued at US$7.294 billion in 2021.

The cell separation market is anticipated to grow at a steady pace throughout the forecast period. Cell separation refers to the process of separating specific types of cells from a mixture or population of cells. The growing prevalence of chronic diseases such as cancer and the expanding biopharmaceutical industry is a major growth driver of the cell separation market. Moreover, the increasing awareness and stem research projects along with the increasing investments in the cell separation market further propelling the cell separation market.

Growing Burden of Chronic and Infectious Diseases

Chronic conditions including cancer, heart disease, and autoimmune illnesses continue to have a serious impact on world health. Techniques for separating cells are essential for understanding disease causes, finding illness biomarkers, and creating specialized treatments. Physicians can monitor how cancer patients respond to various therapies with a minimum of invasiveness by isolating and analyzing circulating tumor cells (CTCs). Therefore, the rising cases of chronic conditions such as cancer are contemplated to bolster the cell separation market. For instance, roughly 10 million deaths, or roughly one in six deaths, were caused by cancer in 2020, making it the top cause of death globally according to the WHO.

Growing Biopharmaceutical Industry

The biopharmaceutical industry is expanding, with increasing investments in research and development of novel therapies and biologics. Cell separation techniques are critical in the production of monoclonal antibodies, recombinant proteins, and cell-based therapies. The biopharmaceutical industry is 3rd largest sector in the world as per the National Investment Promotion & Facilitation Agency (India). The rising investment in the biopharmaceutical industry is directly boosting the cell separation market. For instance, Pharmaceutical Research and Manufacturers of America (PhRMA) reports that over $100 billion was spent on R&D by biopharmaceutical research businesses in the US alone in 2019. Moreover, the managing director of Sun Pharma announced an investment of $600 - $650 in research in February 2022.

Rising Awareness about Stem Cell Research

The study of stem cells has enormous potential for regenerative medicine, disease modeling, and medication development. Effective cell separation techniques are needed for the isolation and characterization of stem cells. The rising awareness about stem cell research and various studies are boosting the cell separation market. The Regenerative Medicine Innovation project was established by the 21st Century Cures Act which was concluded in 2021. The initiative was taken by NIH and FDA to accelerate progress in the field of stem cells. Moreover, the second Wednesday of October is celebrated as Stem Cell Awareness Day by the California Institute for Regenerative Medicine to share the thoughts, ideas, and progress they have made in stem cells and regenerative medicine.

Increasing Investment Initiatives and Government Support

The increasing investments and funding received by the companies involved in cell separation solutions are expected to propel the cell separation market in the coming years. For example, Nodexus Inc. raised $30 million in funding to advance and expand the commercialization of the NX One platform. The NX One platform is the world's first adaptable system to sort and isolate single cells from biological samples. Moreover, government support and grants to advance cell separation solutions are further boosting the cell separation market. For example, Proteios Technology Inc. was awarded a $1.6 million grant from NIH to commercialize its multivariate cell isolation technology in September 2022.

Restraints in the Market

The cell separation market has experienced growth and development, however, some restraints or challenges can impact its expansion. The specificity of cell separation may be constrained by the separation method employed. For example, non-target cells may be co-isolated using magnetic bead-based separation techniques as a result of non-specific binding. To use and comprehend the results of some cell separation techniques, such as fluorescence-activated cell sorting (FACS) or microfluidics, specialized technical knowledge is needed. The lack of experts in poor countries may hinder the cell separation market expansion in the regions. Some cell separation approaches could have throughput and scalability restrictions. This might be a limitation when processing big sample quantities.

North America is anticipated to grow considerably.

North America is expected to hold a significant share of the cell separation market during the forecast period. The factors attributed to such a share are the well-established pharmaceutical and biotech sectors as well as the widespread use of cutting-edge technologies in the US. For instance, the US president launched a biotechnology and biomanufacturing initiative in September 2022 to harness the full potential of biotechnology in the country. Moreover, the higher prevalence of chronic diseases in the region further indicates the need for cell separation products thereby boosting the cell separation market. For instance, cancer is the second-most leading cause of death in the US as per the CDC with around 1.9 million cases in 2021.

Major Market Players

  • Terumo Corporation is a Japanese multinational company that is involved in the development of a wide range of medical devices including products related to cell separation. Through its Terumo BCT (Blood Component Technologies) branch, Terumo provides a range of cell separation and processing technologies.
  • Merck KGaA is a global science and technology company headquartered in Germany. It provides a range of products and services linked to cell separation and adjacent industries. Estapor® Paramagnetic Microspheres are reagents that enable the isolation of desired cells or microorganisms using a straightforward magnet-based approach.
  • STEMCELL Technologies Inc. is a Canadian biotechnology company that focuses on the research, development, and provision of tools, reagents, and services for the fields of stem cell research, cell therapy, and regenerative medicine. Robosep™ - C Human T Cell Isolation Kit, and RoboSep™ -C Tubing Set are some of the products offered by the company as cell separation solutions.

Key Market Developments

  • In May 2023, Akadeum launched a GMP-grade product line for T-cell isolation and expansion. The product uses microbubbles to activate T cells which enable direct leukoplakia human immune cell isolation and T cell activation.
  • In February 2022, GPB Scientific launched its go-to-market Curate® Cell platform to streamline the process of cell therapies and separation.
  • In June 2020, LevitasBio introduced LeviCeIITM, its main product, as a novel approach for cell separation and sorting. It offers a quick, dependable way to sort completely viable cell populations while providing label-free cell separation.

Segmentation:

By Product

  • Consumables
  • Instruments

By Technique

  • Centrifugation
  • Surface Marker
  • Filtration

By Application

  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • Tissue Regeneration
  • In Vitro Diagnostics
  • Therapeutics

By End-Use

  • Research Laboratories and Institutes
  • Hospitals and Diagnostic Laboratories
  • Cell Banks
  • Biotechnology and Biopharmaceutical Companies

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. CELL SEPARATION MARKET, BY PRODUCT

  • 5.1. Introduction
  • 5.2. Consumables
  • 5.3. Instruments

6. CELL SEPARATION MARKET, BY TECHNIQUE

  • 6.1. Introduction
  • 6.2. Centrifugation
  • 6.3. Surface Marker
  • 6.4. Filtration

7. CELL SEPARATION MARKET, BY APPLICATION

  • 7.1. Introduction
  • 7.2. Biomolecule Isolation
  • 7.3. Cancer Research
  • 7.4. Stem Cell Research
  • 7.5. Tissue Regeneration
  • 7.6. In Vitro Diagnostics
  • 7.7. Therapeutics

8. CELL SEPARATION MARKET, BY END-USE

  • 8.1. Introduction
  • 8.2. Research Laboratories and Institutes
  • 8.3. Hospitals and Diagnostic Laboratories
  • 8.4. Cell Banks
  • 8.5. Biotechnology and Biopharmaceutical Companies

9. CELL SEPARATION MARKET, BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. United States
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. United Kingdom
    • 9.4.2. Germany
    • 9.4.3. France
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. The Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. Japan
    • 9.6.2. China
    • 9.6.3. India
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativeness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

  • 11.1. Thermo Fisher Scientific, Inc.
  • 11.2. BD Biosciences
  • 11.3. Danaher
  • 11.4. Terumo Corp.
  • 11.5. STEMCELL Technologies Inc.
  • 11.6. Bio-Rad Laboratories, Inc.
  • 11.7. Merck KGaA
  • 11.8. Agilent Technologies, Inc.
  • 11.9. Corning Inc.
  • 11.10. Akadeum Life Sciences